EC Science Budget Deadlocked

BRUSSELS—European research ministers are making a last-ditch effort to break a stalemate over the Community's five-year budget for research and development. Last month the ministers rejected a Belgian plan for a budget of $6.4 billion (5.8 billion ECU)151;a compromise between the $8.5 billion demanded by the European Commission and the $4.4 billion suggested by the three largest member states (Britain, France and West Germany). At stake is the future of the EEC's collaborative research pro

Written byBernard Dixon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Last month the ministers rejected a Belgian plan for a budget of $6.4 billion (5.8 billion ECU)151;a compromise between the $8.5 billion demanded by the European Commission and the $4.4 billion suggested by the three largest member states (Britain, France and West Germany). At stake is the future of the EEC's collaborative research program, known as Framework, which embraces such projects as Esprit (on information technology), Race (on telecommunications) and Brite (on other industrial technologies). Some 3,000 researchers throughout Europe are paid through Esprit, largest of these cooperative efforts.

Glyn Ford, a member of the European Parliament and former scientist, said hundreds of vital research projects are threatened by the inability of the 12 member nations to reach agreement. "The [low] cash limit being demanded by the British government is not one at which we can compete seriously with the Americans and the Japanese," declared Ford. "The disintegration of existing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies